DRUG — Bright Minds Biosciences Inc. stock price, charts and financials

QT65Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
60.98
-0.57-0.93%
OverviewShort InterestFilings
DRUGQT65Bright Minds Biosciences Inc.·NASDAQ
60.98-0.93%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 17, 20266-KForeign issuer report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026S-8Registration of employee benefit securities
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 03, 20266-KForeign issuer report
Jun 02, 20266-KForeign issuer report
May 28, 20266-KForeign issuer report
May 20, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 13, 20266-KForeign issuer report
Feb 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 09, 20266-KForeign issuer report
Jan 09, 20266-KForeign issuer report
Jan 09, 2026424B5Prospectus
Jan 08, 20266-KForeign issuer report
Jan 07, 20266-KForeign issuer report
#1 / 25 of 172
Page
▼
/ 7